MAIA Biotechnology, Inc. (MAIA)
1.31
-0.02
(-1.50%)
USD |
NYAM |
Aug 31, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 07:32
MAIA Biotechnology Cash from Operations (Annual) : -18.84M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -18.84M |
| December 31, 2024 | -15.70M |
| December 31, 2023 | -13.07M |
| December 31, 2022 | -11.66M |
| Date | Value |
|---|---|
| December 31, 2021 | -4.123M |
| December 31, 2020 | -1.844M |
| December 31, 2019 | -1.565M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| TG Therapeutics, Inc. | -24.77M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |